BAFF-R CAR-T
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BAFF-R CAR-T, covering 2025-06-15 to 2025-12-02. Get the full timeline:
Most recent: Clinical Trial Update: Multicenter, Single-Arm Exploratory Phase I Clinical Study (Assessment of Safety and Efficacy) of Fully Human BAFF-R Chimeric Antigen Receptor T-Cell Injection in Relapsed/Refractory BAFF-R-Positive B-Cell Lymphoma [Phase 1, Phase 2]